Angptl5 restricts primitive hematopoiesis by promoting retinoic acid signaling in zebrafish
PLOS Biology · 25.06.2026 · 24 (6) · e3003858
DOI: 10.1371/journal.pbio.3003858 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 25.06.2026. Verfasst von Jing Mo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Zebrafish, Tretinoin, Hematopoiesis, Zebrafish Proteins. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Science and Technology Program of Guizhou Province.
Abstract (Originalsprache)
Homeostasis is essential for hematopoiesis, and its dysregulation can lead to severe pathological conditions. Retinoic acid (RA) is a key regulator that exerts concentration-dependent effects on both embryonic and adult hematopoiesis. However, the mechanisms that modulate RA signaling in hematopoietic processes remain poorly understood. Using zebrafish as a model, we identified angiopoietin-like protein 5 (Angptl5) as a critical regulator of hematopoietic homeostasis. Loss of Angptl5 function resulted in myeloid hyperplasia in the anterior lateral plate mesoderm (ALPM) and anterior expansion of erythroid progenitors in the posterior lateral plate mesoderm (PLPM)—phenotypes consistent with attenuated RA signaling. Molecular analyses confirmed impaired RA signaling in angptl5 Δ10/Δ10 mutants, and exogenous RA supplementation fully rescued the hematopoietic defects. Mechanistically, we found that Angptl5 transcriptionally activates retinol dehydrogenase dhrs9 through its interaction with Integrin α6lβ5. Our findings establish Angptl5 as a novel and essential regulator of embryonic hematopoiesis and reveal a previously unrecognized mechanism controlling hematopoietic homeostasis. These insights position Angptl5 as a potential therapeutic target for hematological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, China.
- Center for Genetic Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, Zhejiang University, Yiwu, China.
- Institute of Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, and Guizhou Province Key Laboratory for Regenerative Medicine, Guizhou Medical University, Guiyang, Guizhou, China.
ORCID-Profile: Peng-Fei Xu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Science and Technology Program of Guizhou Province
Zitieren
APA
Mo, J., Zhuo, D. H., Gao, M., Huang, Y., Cheng, T., Dong, Y., Xing, Y. Y., Li, Y. F., Jin, Z. X., Liu, X., Zhao, G. Q., Pu, H. R., Liu, Y. M., Shu, L. P., & Xu, P. F. (2026). Angptl5 restricts primitive hematopoiesis by promoting retinoic acid signaling in zebrafish. PLOS Biology, 24(6), e3003858. https://doi.org/10.1371/journal.pbio.3003858
Vancouver
Mo J, Zhuo DH, Gao M, Huang Y, Cheng T, Dong Y, et al. Angptl5 restricts primitive hematopoiesis by promoting retinoic acid signaling in zebrafish. PLOS Biology. 2026;24(6):e3003858. doi:10.1371/journal.pbio.3003858
BibTeX
@article{Mo2026,
author = {Mo, Jing and Zhuo, Ding-Hao and Gao, Min and Huang, Ying and Cheng, Tao and Dong, Yang and Xing, Yan-Yi and Li, Yun-Fei and Jin, Zi-Xin and Liu, Xiang and Zhao, Guo-Qin and Pu, Hai-Rong and Liu, Yu-Meng and Shu, Li-Ping and Xu, Peng-Fei},
title = {Angptl5 restricts primitive hematopoiesis by promoting retinoic acid signaling in zebrafish},
journal = {PLOS Biology},
year = {2026},
volume = {24},
number = {6},
pages = {e3003858},
doi = {10.1371/journal.pbio.3003858}
}
EUVIMED